Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Anahita Mansoori,Gity Sotoudeh,Mahmoud Djalali,Mohammadreza Eshraghian,Mohammad Keramatipour,Ensieh Nasli-Esfahani,Farzad Shidfar,Ehsan Alvandi,Omid Toupchian,Fariba Koohdani

Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

2015

Anahita Mansoori
Gity Sotoudeh
Mahmoud Djalali
Mohammadreza Eshraghian
Mohammad Keramatipour
Ensieh Nasli-Esfahani
Farzad Shidfar
Ehsan Alvandi
Omid Toupchian
Fariba Koohdani

Background: The aims of this research were to investigate (1) the impact of docosahexaenoic acid (DHA)-rich fish oil supplementation on body composition, plasma a

Keywords:

Biology
Placebo
Docosahexaenoic acid
Endocrinology
Adiponectin
Peroxisome proliferator-activated receptor
Type 2 diabetes
Internal medicine
Diabetes mellitus
Type 2 Diabetes Mellitus
Fish oil

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations